anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Psychosocial interventions for supporting women to stop smoking in pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Smoker 5. Young Adult 19-24 years 6. Pregnancy 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Medical treatments for incomplete miscarriage
1. Adult 19-44 years 2. Incomplete Miscarriage 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Miscarriage In First Trimester 6. Pregnancy Loss 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Hypertensive disorder 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Term Pregnancy 6. Premature Rupture Of Membranes 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Hemoglobin SS Disease 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antenatal breastfeeding education for increasing breastfeeding duration
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Nitric oxide donors for cervical ripening and induction of labour
1. Adult 19-44 years 2. Labour Induction 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Viable Fetus 7. Third Trimester Pregnancy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for promoting the initiation of breastfeeding
1. Adult 19-44 years 2. Not Pregnant 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Mother Delivered 7. Low Income 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Chewing gum for enhancing early recovery of bowel function after caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Postpartum 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Effect of restricted pacifier use in breastfeeding term infants for increasing duration of breastfeeding
1. Mother Currently Breast-feeding 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Mother Delivered 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Amnioinfusion for chorioamnionitis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Chorioamnionitis 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Idiopathic Hyperprolactinemia 4. Young Adult 19-24 years 5. History Of Recurrent Miscarriage - Not Delivered 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Third Trimester Pregnancy Less Than 36 Weeks 6. Adolescent 13-18 years 7. Obstetric Problem Affecting Fetus
Provide patient population that should be included in the study
Sealing procedures for preterm prelabour rupture of membranes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Preterm Rupture Of Membranes 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating hyperemesis gravidarum
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Hyperemesis Gravidarum 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Oxytocin for preventing postpartum haemorrhage (PPH) in non‐facility birth settings
1. Delivery Outside Health Facility 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Techniques for assisting difficult delivery at caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Third Stage Of Labor 4. Young Adult 19-24 years 5. Pregnancy 6. Normal Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned caesarean section for women with a twin pregnancy
1. Adult 19-44 years 2. Viable Pregnancy 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Twin Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Twin Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Health system and community level interventions for improving antenatal care coverage and health outcomes
1. Adult 19-44 years 2. Not Pregnant 3. Middle Aged 45-64 years 4. Healthcare Professional 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Use of biochemical tests of placental function for improving pregnancy outcome
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Nutritional advice for improving outcomes in multiple pregnancies
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Multiple Pregnancy 4. Young Adult 19-24 years 5. Pregnancy 6. Nulliparous 7. Birth to 1 mo 8. Multiparous 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Nitroglycerin for management of retained placenta
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Vaginal Delivery 6. Retained Placenta 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Multiple Pregnancy 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Ethanol for preventing preterm birth in threatened preterm labor
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Hospitalization 6. Adolescent 13-18 years 7. Threatened Premature Labour
Provide patient population that should be included in the study
Reduction of the number of fetuses for women with a multiple pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Multiple Pregnancy 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Intermittent oral iron supplementation during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Fetal movement counting for assessment of fetal wellbeing
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Fetal Viability 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antenatal cardiotocography for fetal assessment
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Complication Of Pregnancy 6. Adolescent 13-18 years 7. Fetus At Risk
Provide patient population that should be included in the study
Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Young Adult 19-24 years 6. Gestation Greater Than 20 Weeks 7. Third Trimester Pregnancy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Anti‐D administration in pregnancy for preventing Rhesus alloimmunisation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Rh Negative 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Treatments for breast abscesses in breastfeeding women
1. Mother Currently Breast-feeding 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Breast Abscess 6. Adolescent 13-18 years
Provide patient population that should be included in the study
High feedback versus low feedback of prenatal ultrasound for reducing maternal anxiety and improving maternal health behaviour in pregnancy
1. Adult 19-44 years 2. Ultrasound scan 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Education for contraceptive use by women after childbirth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Expedited versus conservative approaches for vaginal delivery in breech presentation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Vaginal Delivery 6. Breech Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned caesarean section for term breech delivery
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Breech Presentation 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Ultrasound for fetal assessment in early pregnancy
1. Adult 19-44 years 2. First Trimester Pregnancy 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Routine ultrasound in late pregnancy (after 24 weeks' gestation)
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Young Adult 19-24 years 5. Pregnancy 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Tranexamic acid for preventing postpartum haemorrhage
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Vaginal Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Diet or exercise, or both, for preventing excessive weight gain in pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned early delivery versus expectant management for monoamniotic twins
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Monoamniotic Twins 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Fetal and umbilical Doppler ultrasound in normal pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
External cephalic version for breech presentation at term
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Breech Presentation 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Bed rest in singleton pregnancies for preventing preterm birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral analgesia for relieving post‐caesarean pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Postpartum 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Community‐based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Combined hormonal versus nonhormonal versus progestin‐only contraception in lactation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Breast Fed 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for helping to turn term breech babies to head first presentation when using external cephalic version
1. Single Pregnancy 2. Adult 19-44 years 3. Cephalic Version 4. Middle Aged 45-64 years 5. Breech Presentation 6. Young Adult 19-24 years 7. Term Pregnancy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Group versus conventional antenatal care for women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic regimens for postpartum endometritis
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Puerperal Endometritis 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Controlled cord traction for the third stage of labour
1. Gestation Greater Than 24 Weeks 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Vaginal Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic manual rotation for fetal malposition to reduce operative delivery
1. Single Pregnancy 2. Adult 19-44 years 3. Cephalic Version 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Term Pregnancy 7. Fetal Malposition 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Routine perineal shaving on admission in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing or reducing domestic violence against pregnant women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for prelabour rupture of membranes at or near term
1. Adult 19-44 years 2. Spontaneous Rupture Of Membranes 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Early versus late initiation of epidural analgesia for labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Labor Established 4. Young Adult 19-24 years 5. Term Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
High‐dose versus low‐dose oxytocin infusion regimens for induction of labour at term
1. Labour Induction 2. Pregnancy 3. Viable Fetus
Provide patient population that should be included in the study
Antibiotic prophylaxis for third‐ and fourth‐degree perineal tear during vaginal birth
1. Infection 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Third Degree Perineal Tear During Delivery - Delivered 5. Young Adult 19-24 years 6. Fourth Degree Perineal Tear During Delivery - Delivered 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Fetal pulse oximetry for fetal assessment in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Labor 6. Adolescent 13-18 years 7. Fetal Monitoring
Provide patient population that should be included in the study
Fetal assessment methods for improving neonatal and maternal outcomes in preterm prelabour rupture of membranes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Preterm Premature Rupture Of Membranes 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Multiple Pregnancy 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Magnesium sulphate for preventing preterm birth in threatened preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Young Adult 19-24 years 5. Premature Labor 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical techniques for uterine incision and uterine closure at the time of caesarean section
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Combination of tocolytic agents for inhibiting preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Preterm Spontaneous Labor With Preterm Delivery 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia
1. Thrombophilia 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Miscarriage 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term
1. Pregnancy 2. Viable Fetus 3. Third Trimester Pregnancy
Provide patient population that should be included in the study
Oral misoprostol for induction of labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Viable Fetus 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Extra fluids for breastfeeding mothers for increasing milk production
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Breast Fed 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Oxytocin receptor antagonists for inhibiting preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Calcium channel blockers for inhibiting preterm labour and birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Prostaglandins for management of retained placenta
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Vaginal Delivery 6. Retained Placenta 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Nitric oxide donors for treating preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned home versus hospital care for preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks' gestation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Preterm Premature Rupture Of Membranes 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Indwelling bladder catheterisation as part of intraoperative and postoperative care for caesarean section
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Delivery By Elective Cesarean Section 5. Delivery By Emergency Cesarean Section 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Intact Membranes 6. Adolescent 13-18 years 7. Threatened Premature Labour
Provide patient population that should be included in the study
Tocolytics for preterm premature rupture of membranes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Preterm Premature Rupture Of Membranes 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Treatment for primary postpartum haemorrhage
1. Adult 19-44 years 2. First Trimester Pregnancy 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Postpartum Hemorrhage 6. Young Adult 19-24 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Elective birth at 37 weeks’ gestation for women with an uncomplicated twin pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Term Pregnancy 6. Twin Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions at caesarean section for reducing the risk of aspiration pneumonitis
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Hyaluronidase for reducing perineal trauma
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Primiparous 6. Second stage of labor 7. Vaginal Delivery 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Betamimetics for inhibiting preterm labour
1. Spontaneous Onset Of Labor 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Premature Labor 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Progestational agents for treating threatened or established preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Intact Membranes 7. Adolescent 13-18 years 8. Threatened Premature Labour
Provide patient population that should be included in the study
Interventions for the treatment of twin‐twin transfusion syndrome
1. Adult 19-44 years 2. Monochorionic Twin Pregnancy 3. Fetus Normal 4. Middle Aged 45-64 years 5. Oligohydramnios 6. Young Adult 19-24 years 7. Twin-to-twin Blood Transfer 8. Adolescent 13-18 years 9. Hydramnios
Provide patient population that should be included in the study
Amnioinfusion for meconium‐stained liquor in labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Normal Labor 6. Meconium Stained Liquor 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean birth
1. Adult 19-44 years 2. Previous Caesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Methods of repair for obstetric anal sphincter injury
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Anal Sphincter Injury 4. Young Adult 19-24 years 5. Repair Of Anal Sphincter 6. Mother Delivered 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Fetal manipulation for facilitating tests of fetal wellbeing
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic antibiotics for inhibiting preterm labour with intact membranes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Labor Established 5. Young Adult 19-24 years 6. Premature Labor 7. Intact Membranes 8. Third Trimester Pregnancy 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for preterm rupture of membranes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Preterm Premature Rupture Of Membranes 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Postnatal parental education for optimizing infant general health and parent‐infant relationships
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Infant 1 to 23 mo 4. Parent 5. Young Adult 19-24 years 6. Birth to 1 mo 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Vaginal Delivery 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Second Trimester Pregnancy 4. Young Adult 19-24 years 5. Threatened Premature Labor - Not Delivered 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Combined oestrogen and progesterone for preventing miscarriage
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Maternal Dystocia 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Package of care for active management in labour for reducing caesarean section rates in low‐risk women
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Caesarean section versus vaginal delivery for preterm birth in singletons
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Restricting oral fluid and food intake during labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Labor 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Relaxin for preventing preterm birth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Premature Labor 6. Adolescent 13-18 years 7. Threatened Premature Labour
Provide patient population that should be included in the study
Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care
1. Spontaneous Onset Of Labor 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Slow Progress In First Stage Of Labor 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Internal versus external tocodynamometry during induced or augmented labour
1. Adult 19-44 years 2. Labour Induction 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Oligohydramnios 4. Young Adult 19-24 years 5. Pregnancy 6. Preterm Premature Rupture Of Membranes 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth
1. Short Cervical Length In Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Multiple Pregnancy 5. Young Adult 19-24 years 6. Pregnancy 7. High Risk Pregnancy Due To History Of Preterm Labor 8. Adolescent 13-18 years 9. Threatened Premature Labour
Provide patient population that should be included in the study
Interventions for supporting pregnant women's decision‐making about mode of birth after a caesarean
1. Adult 19-44 years 2. Previous Caesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Castor oil, bath and/or enema for cervical priming and induction of labour
1. Adult 19-44 years 2. Labour Induction 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Third Trimester Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Diet or exercise, or both, for weight reduction in women after childbirth
1. Adult 19-44 years 2. Obesity 3. Middle Aged 45-64 years 4. Excessive Weight Gain 5. Young Adult 19-24 years 6. Abnormal Weight Gain In Pregnancy 7. Mother Delivered 8. Adolescent 13-18 years 9. Overweight
Provide patient population that should be included in the study
Enemas during labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. First Stage Of Labor 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Telephone support for women during pregnancy and the first six weeks postpartum
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Mother Delivered 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Postpartum misoprostol for preventing maternal mortality and morbidity
1. Gestation Greater Than 24 Weeks 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
High‐dose versus low‐dose oxytocin for augmentation of delayed labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Viable Fetus 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Finding Of Umbilical Cord Clamp 4. Term Pregnancy Delivered 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries
1. Spontaneous Onset Of Labor 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Epidural Anesthesia 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Oxytocin versus no treatment or delayed treatment for slow progress in the first stage of spontaneous labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Support for mothers, fathers and families after perinatal death
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Fetal Death 4. Young Adult 19-24 years 5. Perinatal Period 6. Pregnancy Loss 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Intravenous fluids for reducing the duration of labour in low risk nulliparous women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Nulliparous 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Amniotomy for shortening spontaneous labour
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antispasmodics for labour
1. Adult 19-44 years 2. Primigravida 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Multigravida 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Umbilical cord antiseptics for preventing sepsis and death among newborns
1. Neonate 2. Birth to 1 mo
Provide patient population that should be included in the study
Cervical pessary for preventing preterm birth
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Multiple Pregnancy 5. Young Adult 19-24 years 6. Pregnancy 7. Viable Fetus 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Antenatal immunoglobulin for fetal red blood cell alloimmunization
1. Pregnancy
Provide patient population that should be included in the study
Maternal position during caesarean section for preventing maternal and neonatal complications
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Anti‐D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Rh Negative 5. Miscarriage 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Methods for administering subcutaneous heparin during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for supporting parents’ decisions about autopsy after stillbirth
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Stillbirth 5. Gestation Greater Than 20 Weeks 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for mastitis in breastfeeding women
1. Adult 19-44 years 2. Mastitis 3. Middle Aged 45-64 years 4. Lactating Breast 5. Young Adult 19-24 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Magnesium sulphate for women at term for neuroprotection of the fetus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Term Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Morning versus evening induction of labour for improving outcomes
1. Adult 19-44 years 2. Labour Induction 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Abdominal decompression in normal pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Ethnic Group 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions to improve water quality and supply, sanitation and hygiene practices, and their effects on the nutritional status of children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics prior to or at the time of embryo transfer in ART
1. Embryo Transfer
Provide patient population that should be included in the study
In vitro fertilisation for unexplained subfertility
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Unexplained Infertility
Provide patient population that should be included in the study
Timed intercourse for couples trying to conceive
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Trying To Conceive 5. Unexplained Infertility
Provide patient population that should be included in the study
Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility
1. Sperm Normal
Provide patient population that should be included in the study
Non‐surgical therapies for Peyronie's disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Peyronie's disease 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Progestin intrauterine devices versus copper intrauterine devices for emergency contraception
1. Emergency contraception
Provide patient population that should be included in the study
Follicular flushing during oocyte retrieval in assisted reproductive techniques
1. Adult 19-44 years 2. In Vitro Fertilization 3. Intracytoplasmic sperm injection 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. Young Adult 19-24 years 5. Intrauterine Insemination 6. Natural Contraception
Provide patient population that should be included in the study
Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse
1. Sexual Intercourse 2. Trying To Conceive 3. Intrauterine Insemination
Provide patient population that should be included in the study
Cleavage‐stage versus blastocyst‐stage embryo transfer in assisted reproductive technology
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. In Vitro Fertilization 4. Oocyte donor 5. Young Adult 19-24 years 6. Direct Injection Of Sperm Into Cytoplasm Of The Oocyte 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Growth hormone for in vitro fertilisation (IVF)
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Infertility 4. Young Adult 19-24 years 5. Infertility Care
Provide patient population that should be included in the study
Oxytocin antagonists for assisted reproduction
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Embryo Transfer 4. Young Adult 19-24 years 5. Assisted reproductive techniques
Provide patient population that should be included in the study
Surgical or radiological treatment for varicoceles in subfertile men
1. Adult 19-44 years 2. Varicocele 3. Middle Aged 45-64 years 4. Subfertility 5. Young Adult 19-24 years 6. Unexplained Infertility
Provide patient population that should be included in the study
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. In Vitro Fertilization 5. Young Adult 19-24 years 6. Ovarian Hyperstimulation
Provide patient population that should be included in the study
Selective serotonin re‐uptake inhibitors for premature ejaculation in adult men
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Premature Ejaculation
Provide patient population that should be included in the study
Fresh versus frozen embryo transfers in assisted reproduction
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. In Vitro Fertilization 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
1. Adult 19-44 years 2. Frozen Embryo Transfer 3. Endometrial preparation 4. Middle Aged 45-64 years 5. In Vitro Fertilization 6. Oocyte donor 7. Infertility 8. Young Adult 19-24 years
Provide patient population that should be included in the study
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. In Vitro Fertilization 5. Repeated implantation failure 6. Female Infertility Due To Advanced Maternal Age 7. Testicular Sperm Extraction 8. Recurrent Miscarriage 9. Prognosis Good
Provide patient population that should be included in the study
Hyaluronic acid in embryo transfer media for assisted reproductive technologies
1. Adult 19-44 years 2. Frozen Embryo Transfer 3. Middle Aged 45-64 years 4. In Vitro Fertilization 5. Oocyte donor 6. Young Adult 19-24 years 7. Direct Injection Of Sperm Into Cytoplasm Of The Oocyte
Provide patient population that should be included in the study
Number of embryos for transfer following in vitro fertilisation or intra‐cytoplasmic sperm injection
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. In Vitro Fertilization 5. Embryo Transfer 6. Young Adult 19-24 years
Provide patient population that should be included in the study
Fluid and pharmacological agents for adhesion prevention after gynaecological surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. Anti-adhesion therapy 5. Middle Aged 45-64 years 6. Gynaeocological Condition 7. Young Adult 19-24 years 8. Laparoscopy 9. Laparotomy 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Barrier agents for adhesion prevention after gynaecological surgery
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pelvic surgery 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Intra‐uterine insemination for unexplained subfertility
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Unexplained Infertility
Provide patient population that should be included in the study
Regular (ICSI) versus ultra‐high magnification (IMSI) sperm selection for assisted reproduction
1. Adult 19-44 years 2. Subfertility 3. In Vitro Fertilization 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
1. Adult 19-44 years 2. Anovulation 3. Subfertility 4. Young Adult 19-24 years 5. Clomiphene-resistant Polycystic Ovary Syndrome 6. Polycystic Ovarian Syndrome
Provide patient population that should be included in the study
Surgical treatment of fibroids for subfertility
1. Uterine fibroid 2. Adult 19-44 years 3. Subfertility 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Granulocyte‐colony stimulating factor administration for subfertile women undergoing assisted reproduction
1. Adult 19-44 years 2. Frozen Embryo Transfer 3. Middle Aged 45-64 years 4. In Vitro Fertilization 5. Embryo Transfer 6. Intracytoplasmic sperm injection 7. Young Adult 19-24 years
Provide patient population that should be included in the study
Semen preparation techniques for intrauterine insemination
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. Young Adult 19-24 years 5. Intrauterine Insemination
Provide patient population that should be included in the study
Temperature of embryo culture for assisted reproduction
1. Adult 19-44 years 2. Subfertility 3. In Vitro Fertilization 4. Intracytoplasmic sperm injection 5. Young Adult 19-24 years
Provide patient population that should be included in the study
Interventions for unexplained infertility: a systematic review and network meta‐analysis
1. Adult 19-44 years 2. Young Adult 19-24 years 3. Unexplained Infertility
Provide patient population that should be included in the study
Time‐lapse systems for embryo incubation and assessment in assisted reproduction
1. Adult 19-44 years 2. Subfertility 3. In Vitro Fertilization 4. Young Adult 19-24 years 5. Embryo Incubation
Provide patient population that should be included in the study
Strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Hormonal Contraception 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions using social networking sites to promote contraception in women of reproductive age
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Contraception 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for emergency contraception
1. Adult 19-44 years 2. Normal Periods 3. Middle Aged 45-64 years 4. Unprotected Sexual Intercourse 5. Young Adult 19-24 years 6. Adolescent 13-18 years